Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A
15(100.0%)
15Total
N/A(15)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06130501Not ApplicableActive Not Recruiting

tAN for PTSD and OUD in Buprenorphine Therapy

Role: collaborator

NCT05129020Not ApplicableActive Not Recruiting

Neurostimulation to Improve NOWS Outcomes

Role: lead

NCT07326722Not ApplicableRecruiting

Delivering tAN to Reduce HMB: The LUNA Study

Role: lead

NCT07109349Not ApplicableRecruiting

tAN for First Responders

Role: lead

NCT06487533Recruiting

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Role: lead

NCT07281261Not ApplicableRecruiting

tAN for Substance Use Disorder

Role: lead

NCT06814028Not ApplicableCompleted

Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial

Role: lead

NCT06390267Not ApplicableCompleted

Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction

Role: lead

NCT05053503Not ApplicableCompleted

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

Role: lead

NCT06782360Not ApplicableRecruiting

Cognitive Augmentation Via Multimodal Sensing and Auricular Neurostimulation

Role: collaborator

NCT06064851Not ApplicableCompleted

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

Role: collaborator

NCT05591703Completed

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

Role: lead

NCT05977946Not ApplicableCompleted

Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects

Role: lead

NCT06647017Not ApplicableNot Yet Recruiting

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Role: collaborator

NCT04588519Not ApplicableCompleted

tAN to Mitigate Withdrawal Behaviors in Neonates

Role: lead

NCT04731935Not ApplicableCompleted

Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Role: lead

NCT04075214Not ApplicableCompleted

Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Role: lead

All 17 trials loaded